The Relevance of Hyperuricemia and Metabolic Syndrome and the Effect of Blood Lead Level on Uric Acid Concentration in Steelmaking Workers.
- Author:
Deul LEE
1
;
Won Jun CHOI
;
Jae Seok OH
;
Min Kee YI
;
Sung Woo HAN
;
Jong Wan YUN
;
Sang Hwan HAN
Author Information
1. Department of Occupational & Environmental Medicine, Gachon University Gil Medical Center, Incheon, Korea. hansh@gachon.ac.kr
- Publication Type:Original Article
- Keywords:
Lead;
Uric acid;
Metabolic syndrome
- MeSH:
Cardiovascular Diseases;
Hematologic Tests;
Humans;
Hyperuricemia*;
Male;
Odds Ratio;
Prevalence;
Risk Factors;
Steel;
Uric Acid*
- From:Annals of Occupational and Environmental Medicine
2013;25(1):27-
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: Uric acid concentration is known to increase the prevalence of metabolic syndrome by affecting its components, resulting in increased risk of cerebrovascular and cardiovascular diseases, and long-term lead exposure is known to affect this serum uric acid level. In this study, we aimed to examine the association between the causes of hyperuricemia and metabolic syndrome, and to determine whether an increased blood lead level affects hyperuricemia. METHOD: Anthropometric measurements, surveys, and blood tests were conducted between May and June 2012 in 759 men working in the steelmaking process at a domestic steel company. Workers were divided into 2 groups according to the presence or absence of hyperuricemia, and an analysis was performed to examine its association with metabolic syndrome. In addition, the workers were divided into 3 groups according to the blood lead level to analyze the association between blood lead and hyperuricemia. RESULTS: The geometric mean (standard deviation) of the blood lead levels in the hyperuricemia group was significantly higher than that of the healthy group (3.8 [1.8] vs. 3.3 [1.8] microg/dL). The adjusted odds ratio for metabolic syndrome of the hyperuricemia group increased significantly to 1.787 (1.125-2.839) compared with the healthy group. In addition, the adjusted odds ratios for the occurrence of hyperuricemia in the tertile 2 (2.61-4.50 microg/dL) and tertile 3 groups (>4.50 microg/dL) according to blood lead level significantly increased to 1.763 (1.116-2.784) and 1.982 (1.254-3.132), respectively, compared with the tertile 1 group (< 2.61 microg/dL). CONCLUSION: Hyperuricemia is believed to function as an independent risk factor for metabolic syndrome, while lead seems to increase the serum uric acid level even at a considerably low blood level. Therefore, attention should be given to patients with hyperuricemia and metabolic syndrome who are prone to lead exposure, and a prospective study should be conducted to identify their causal relationship.
